These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 10913432)

  • 1. Hyperlipidemia associated with the use of protease inhibitors.
    Smith JH; Martin GJ; Decker CF
    Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
    Chang ES; Tetreault DD; Liu YT; Beall GN
    J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetes and hyperglycemia in patients under treatment for HIV infection with the protease inhibitors indavir, ritonavir, saquinavir as well as nelfinavir (in development, but not yet released].
    Pharm Unserer Zeit; 1997 Dec; 26(6):317. PubMed ID: 9513575
    [No Abstract]   [Full Text] [Related]  

  • 4. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.
    Périard D; Telenti A; Sudre P; Cheseaux JJ; Halfon P; Reymond MJ; Marcovina SM; Glauser MP; Nicod P; Darioli R; Mooser V
    Circulation; 1999 Aug; 100(7):700-5. PubMed ID: 10449690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.
    Baldini F; Di Giambenedetto S; Cingolani A; Murri R; Ammassari A; De Luca A
    AIDS; 2000 Jul; 14(11):1660-2. PubMed ID: 10983656
    [No Abstract]   [Full Text] [Related]  

  • 6. Using ritonavir with indinavir in cases of virologic failure.
    TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
    [No Abstract]   [Full Text] [Related]  

  • 7. Ritonavir and indinavir one year later.
    TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094
    [No Abstract]   [Full Text] [Related]  

  • 8. Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
    Kosalaraksa P; Bunupuradah T; Engchanil C; Boonrak P; Intasan J; Lumbiganon P; Burger D; Ruxrungtham K; Schutz M; Ananworanich J;
    Pediatr Infect Dis J; 2008 Jul; 27(7):623-8. PubMed ID: 18520443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaletra versus nelfinavir.
    TreatmentUpdate; 2001; 12(12):8-10. PubMed ID: 11570097
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for ritonavir intolerance and outcome after change to indinavir.
    Casado JL; Perez-Elías MJ; Antela A; Martí-Belda P; de Lucas S; Muñoz V; Guerrero A
    AIDS; 1998 Feb; 12(3):335-6. PubMed ID: 9580044
    [No Abstract]   [Full Text] [Related]  

  • 11. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
    Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA
    AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient's guide to protease inhibitors.
    Elperin A; Sax P
    AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors and blood sugar problems.
    TreatmentUpdate; 2001 Jun; 13(2):8. PubMed ID: 11570291
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
    Klaus BD; Grodesky MJ
    Nurse Pract; 1998 Feb; 23(2):102-4, 106. PubMed ID: 9513221
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV protease inhibitors: advances in therapy and adverse reactions, including metabolic complications.
    Kaul DR; Cinti SK; Carver PL; Kazanjian PH
    Pharmacotherapy; 1999 Mar; 19(3):281-98. PubMed ID: 10221367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and antiviral effect of protease inhibitors in children.
    Temple ME; Koranyi KI; Nahata MC
    Pharmacotherapy; 2001 Mar; 21(3):287-94. PubMed ID: 11253853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What they say about protease inhibitors.
    Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protease inhibitors on the sense of taste.
    Schiffman SS; Zervakis J; Heffron S; Heald AE
    Nutrition; 1999 Oct; 15(10):767-72. PubMed ID: 10501290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid lowering therapy in patients with HIV infection.
    McBride M; Chin MT; Lee SM; Kelly B
    Lancet; 1998 Nov; 352(9142):1782-3. PubMed ID: 9848377
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of HIV protease inhibitors: a survey.
    Ren S; Lien EJ
    Prog Drug Res; 1998; 51():1-31. PubMed ID: 9949858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.